Risk factors for interval advanced colorectal neoplasia after screening colonoscopy.

Authors

Laura Musselwhite

Laura W. Musselwhite

Herbert Yeargan Center for Global Health, Duke University Medical Center, Durham, NC

Laura W. Musselwhite , Catherine M. Thomas , David H. Abbott , Elizabeth R. Hauser , Laura K. Wagner , Sara F. Morris , David G. Weiss , David A. Lieberman , Dawn T. Provenzale

Organizations

Herbert Yeargan Center for Global Health, Duke University Medical Center, Durham, NC, Cooperative Studies Program Epidemiology Center, Durham Veteran Affairs Medical Center, Durham, NC, Health Services Research and Development, Durham Veteran Affairs Medical Center, Durham, NC, Cooperative Studies Program Epidemiology Center, Durham Veterans Affairs Medical Center, Durham, NC, Cooperative Studies Program Epidemiology Center, Durham Veteran Affairs Medical Center, Durham, NC, Cooperative Studies Program, Perry Point VA Medical Center, Perry Point, VA, Oregon Health & Science University, Portland, OR

Research Funding

No funding sources reported

Background: Knowledge of risk factors for interval colorectal neoplasia could inform screening strategies in asymptomatic individuals. Few studies have evaluated risk factors for advanced neoplasia at 5 years in individuals who have had screening colonoscopy. Methods: We studied 1193 participants aged 50-75 to identify factors associated with interval advanced neoplasia during a 5-year follow-up period. Participants underwent screening and 5-year colonoscopy from 1994-1997 at 13 Veterans Affairs Medical Centers. Advanced neoplasia included an adenoma ≥ 1cm, villous histology, high-grade dysplasia, or carcinoma. Risk factors were self-reported at baseline. We performed a multivariable logistic regression analysis of risk for interval advanced neoplasia, adjusting for age, smoking, alcohol use, BMI, colon cancer in first degree relatives, diabetes, cardiovascular disease, and prior outcome. Results: Participants were mostly male (97%) and white (83%). At 5 years, 392 participants (33%) had small adenomas < 1cm, and 92 participants (7.7%) had advanced neoplasia. In multivariable analyses, risk for interval advanced neoplasia was associated with age in 10-year increments (OR, 2.09; 95% CI, 1.39-3.13), diabetes (OR, 1.95; 95% CI, 1.12-3.41), prior small adenomas (OR, 4.02; 95% CI, 1.65-9.80), and prior advanced neoplasia (OR, 12.41; 95% CI, 5.08-30.30). Conclusions: In this prospective screening study, we identified diabetes as an independent risk factor for interval advanced neoplasia. Future guidelines should consider enhanced follow up of diabetic patients.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Citation

J Clin Oncol 33, 2015 (suppl; abstr 3539)

DOI

10.1200/jco.2015.33.15_suppl.3539

Abstract #

3539

Poster Bd #

31

Abstract Disclosures

Similar Abstracts

First Author: Shai Friedland

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Trends in colorectal cancer screening from NHIS survey: Analysis of modalities impact on overall screening.

First Author: Derek W. Ebner

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Impact of revising colorectal cancer screening guidelines on health care resources in Canada.

First Author: Brendan Chia